Davis Capital Management
TMDX icon

Davis Capital Management’s Transmedics TMDX Stock Holding History

Davis Capital Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$167 Hold
2
– – ﹤0.01% 907
2026
Q2 		$133 Buy
+2
New +$169 ﹤0.01% 988

Other funds holding TMDX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Emerald Advisers
Emerald Advisers Leola, Pennsylvania $3.64B AUM 71.19% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Wasatch Advisors
Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Emerald Mutual Fund Advisers Trust
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.45B AUM 70.46% 1-Year Est. Return
Zevenbergen Capital Investments
Zevenbergen Capital Investments Edmonds, Washington $4.37B AUM 52.9% 1-Year Est. Return

Davis Capital Management's TMDX Position: Q3 2026 in Review

Davis Capital Management held its Transmedics (TMDX) position steady in Q3 2026 at 2 shares worth $167. The position accounts for ﹤0.01% of the portfolio, ranked #907.

Davis Capital Management first reported a position in TMDX in Q2 2026 and has held it in 2 quarters since. 217 funds tracked by Wall St. Rank hold TMDX as of Q3 2026.

  • Davis Capital Management held 2 shares of Transmedics worth $167 as of Q3 2026.
  • Davis Capital Management left its Transmedics share count unchanged in Q3 2026.
  • Transmedics made up ﹤0.01% of Davis Capital Management's portfolio in Q3 2026, its #907 holding.
  • Davis Capital Management first reported a position in Transmedics in Q2 2026 and has held it in 2 quarters since.
  • 217 funds tracked by Wall St. Rank held Transmedics as of Q3 2026.

Based on Davis Capital Management's 13F filing for Q3 2026, filed 8 Oct 2026.